Although the PNPLA3 rs738409 variant G allele is undoubtedly more frequent in cancers compared to controls, there was also a significant difference between the cirrhotic versus the non-cirrhotic cases with NAFLD-HCC (red text Table 3, p < 0.0001). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.